can you withdraw from semaglutide The Pros and Cons of for Weight Loss November Blog - What happens

In this narrative literature review, we explore the pharmacological properties of tirzepatide and critically summarize and comment on the results of the clinical studies conducted thus far, as well as discuss the potential implications for the treatment of obesity, T2DM, and associated cardiometabolic complications

Who Experiences More Side Effects: Higher Risk of Side Effects: Women (higher rates than men) Starting at higher doses Rapid dose escalation History of GI issues (GERD, IBS) Slower metabolism Older age Lower Risk of Side Effects: Men (lower rates than women) Gradual dose escalation Prior GLP-1 exposure Following dietary recommendations Managing Side Effects Successfully: Diet Modifications: Foods to Emphasize: Lean proteins (chicken, fish, eggs) Non-starchy vegetables Clear broths and soups Crackers, toast (for nausea) Ginger (natural anti-nausea) Peppermint tea Foods to Avoid: Fatty, greasy foods (worsen nausea) Spicy foods (irritate GI tract) Large portions (harder to digest) Carbonated drinks (increase bloating) Alcohol (worsens nausea, dehydration) High-sugar foods (blood sugar swings) Eating Strategies: Small, frequent meals (5-6 times daily) Eat slowly, chew thoroughly Stop when satisfied (dont push to full) Stay upright after eating (prevents reflux) Dont drink large amounts with meals When to Contact Your Provider: Urgent (Call Immediately): Severe abdominal pain Persistent vomiting (cant keep fluids down) Signs of dehydration (dark urine, dizziness, confusion) Severe allergic reaction Vision changes Symptoms of pancreatitis Non-Urgent (Schedule Appointment): Side effects not improving after 4 weeks Want to discuss slowing dose escalation Questions about managing side effects Considering anti-nausea medication Weight loss plateau concerns Discontinuation Rates: Due to Side Effects: Semaglutide: 6.9% discontinue Tirzepatide: 6.2% discontinue Over 93% of patients tolerate well enough to continue Long-Term Safety: Semaglutide: On market since 2017 (8 years) Extensive real-world safety data SELECT trial: Actually reduced cardiovascular events (20% reduction) No new safety concerns with longer use Tirzepatide: On market since 2022 (3 years) Growing real-world safety data Clinical trials show excellent safety profile Cardiovascular outcomes trial ongoing Both medications appear safe for long-term use based on available evidence

Muscle Loss Prevention in Men on GLP-1 Therapy One of the biggest concerns for men taking semaglutide is losing muscle alongside fata risk that's higher in men than in women because male physiology depends more heavily on lean mass for metabolic function

Both oral and injectable GLP-1s have a long half-life (about one week) I typically recommend stopping them at least 2 weeks before surgery This helps ensure proper nutrition, safer anesthesia, and better healing Weight loss drugs are powerful, but surgery requires your body to be well-nourished

los artculos de fase 2 aparecieron en 2023 y los estudios posteriores se agrupan bajo el programa TRIUMPH

Extremely short-l Every compound compared in one table: dose range, how often, half-life and evidence tier.